Literature DB >> 7794071

Mechanisms of transplant right ventricular dysfunction.

P Van Trigt1, H B Bittner, S W Kendall, C A Milano.   

Abstract

OBJECTIVE: Right ventricular (RV) dysfunction remains the leading cause of early mortality after cardiac transplantation. The effect of brain death and subsequent hypothermic cardioplegic arrest and storage on subsequent post-transplant right ventricular function was examined. SUMMARY BACKGROUND DATA: Right ventricular dysfunction in the donor heart usually is attributed to failure of the donor right ventricle to adapt to the sudden increase in afterload (pulmonary vascular resistance) in the recipient. Strategies to improve ventricular mechanics in the postoperative period are aimed at reducing pulmonary vascular resistance with vasodilators or augmenting right ventricular contractility with inotropic agents. Events occurring in the donor heart (brain death, hypothermic cardioplegic arrest, and storage) also may be directly related to post-transplant RV dysfunction.
METHODS: A canine model of brain death and orthotopic cardiac transplantation was used. A dynamic pressure-volume analysis of RV mechanics was performed using micromanometers and sonomicrometric dimension transducers. Systolic function was assessed by measurement of preload recruitable stroke work (PRSW). Brain death was induced in 17 dogs by inflation of an intracranial balloon. Right ventricular function then was assessed serially to 6 hours (PRSW). Right ventricular adrenergic beta receptor density and function was sampled at control and after 6 hours of brain death. The effect of cardioplegic arrest and hypothermic storage was assessed in a second group of 17 dogs, using the same instrumentation and method of RV analysis.
RESULTS: A significant decrease in right ventricular PRSW occurred after brain death, with the average decrease being 37% +/- 10.4% from the control. The RV myocardial beta adrenergic receptor density did not significantly change (253 +/- 34 fmol/ng control vs. 336 +/- 54 fmol/ng after brain death). The adenylyl cyclase activity of the RV beta receptor was assessed and was not altered by brain death. Orthotopic transplantation after cardioplegic arrest and hypothermic storage significantly decreased RV PRSW from 23.6 +/- 2.0 x 10(3) erg to 13.5 +/- 1.4 x 10(3) erg.
CONCLUSIONS: These data indicate that the donor right ventricle is exposed to factors significantly detrimental to its mechanical performance well before facing an increased afterload in the recipient. Strategies to reduce RV dysfunction associated with brain death and hypothermic storage could positively impact post-transplant survival.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7794071      PMCID: PMC1234692          DOI: 10.1097/00000658-199506000-00006

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  17 in total

1.  Effect of donor heart damage on survival after transplantation.

Authors:  S Darracott-Cankovic; P G Stovin; D Wheeldon; J Wallwork; F Wells; T A English
Journal:  Eur J Cardiothorac Surg       Date:  1989       Impact factor: 4.191

2.  Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors.

Authors:  D Novitzky; D K Cooper; B Reichart
Journal:  Transplantation       Date:  1987-06       Impact factor: 4.939

3.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

4.  Cardiac injury and subarachnoid hemorrhage. A clinical, pathological, and physiological correlation.

Authors:  J H Greenhoot; D D Reichenbach
Journal:  J Neurosurg       Date:  1969-05       Impact factor: 5.115

5.  Analysis of morbid events and risk factors for death after cardiac transplantation.

Authors:  J K Kirklin; D C Naftel; D C McGiffin; R F McVay; E H Blackstone; R B Karp
Journal:  J Am Coll Cardiol       Date:  1988-05       Impact factor: 24.094

Review 6.  Beta-adrenergic function in heart muscle disease and heart failure.

Authors:  M R Bristow; N E Kantrowitz; R Ginsburg; M B Fowler
Journal:  J Mol Cell Cardiol       Date:  1985-07       Impact factor: 5.000

Review 7.  Experimental catecholamine-induced myocardial necrosis. I. Morphology, quantification and regional distribution of acute contraction band lesions.

Authors:  G L Todd; G Baroldi; G M Pieper; F C Clayton; R S Eliot
Journal:  J Mol Cell Cardiol       Date:  1985-04       Impact factor: 5.000

8.  Orthotopic heart transplantation with bicaval and pulmonary venous anastomoses.

Authors:  C Blanche; M Valenza; L S Czer; P Barath; D Admon; D Harasty; C Utley; D Freimark; I Aleksic; J Matloff
Journal:  Ann Thorac Surg       Date:  1994-11       Impact factor: 4.330

9.  Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work.

Authors:  D D Glower; J A Spratt; N D Snow; J S Kabas; J W Davis; C O Olsen; G S Tyson; D C Sabiston; J S Rankin
Journal:  Circulation       Date:  1985-05       Impact factor: 29.690

10.  Vasopressin supplementation in a porcine model of brain-dead potential organ donors.

Authors:  E M Blaine; R D Tallman; D Frolicher; M A Jordan; L L Bluth; M B Howie
Journal:  Transplantation       Date:  1984-11       Impact factor: 4.939

View more
  2 in total

1.  Low-Dose Donor Dopamine Is Associated With a Decreased Risk of Right Heart Failure in Pediatric Heart Transplant Recipients.

Authors:  Marc E Richmond; Rachel Easterwood; Rakesh K Singh; Lisa Gilmore; Kimberly Beddows; Warren A Zuckerman; Eric D McFeely; Jonathan M Chen; Linda J Addonizio
Journal:  Transplantation       Date:  2016-12       Impact factor: 4.939

2.  [Evaluation of the potential organ donor with special regards to heart donation].

Authors:  Daniel Höfer; Arezu Aliabadi; Christian Ebner; Christoph Hörmann; Stephane Mahr; Regina Mascherbauer; Gerhard Pölzl; Albert Reiter; Andrä Wasler; Thomas Weber; Michael Zink; Andreas Zuckermann; Herwig Antretter
Journal:  Wien Klin Wochenschr       Date:  2010-07-16       Impact factor: 1.704

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.